NCT06958692 - A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder | Biotech Hunter

Enrollment

388

Participants

Timeline

Start Date

April 11, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 30, 2026

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG

Dextromethorphan and Bupropion Sustained-Release Tablets

Oral dextromethorphan and bupropion sustained-release tablets, taken daily for 6 weeks.

DRUG

Placebo

Oral placebo tablets, taken daily for 6 weeks.

Trial Locations (1)

RECRUITING

Beijing Anding Hospital Affiliated to Capital Medical University, Beijing